AI Platform & Growth Accelerator for Revenue Teams - Lantern
Browse, deploy, and customize AI agents that automate every critical revenue function—from champion tracking to intent monitoring, all available in minutes.
withlantern.comThe Lantern is described as an AI-driven revenue tool aimed at accelerating revenue workflows, with claims of 28% faster deal velocity and automated outreach. The Champion Agent monitors personnel shifts across the customer base to automate outreach for certain teams. In pharma, Lantern Pharma reports 2026 progress, cutting R&D spend by 47% while advancing multiple clinical programs, launching a multi-agent AI platform with Zeta.ai and expanding an AI Center of Excellence in India to scale RADR. These items illustrate Lantern's expansion into AI-powered drug discovery partnerships, supported by ongoing financing to fuel expansion.
Browse, deploy, and customize AI agents that automate every critical revenue function—from champion tracking to intent monitoring, all available in minutes.
withlantern.comLantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform...
www.innovationopenlab.comnews
www.newswire.calantern News and Updates from The Economictimes.com
economictimes.indiatimes.comDisciplined Execution Drives 47% Reduction in R&D Spend While Advancing Multiple Clinical Programs, Launching Multi-Agentic AI Platform withZeta.ai Commercially, and Strengthening Balance Sheet with Financing of up to $9.25 Million
natlawreview.comDisciplined Execution Drives 47% Reduction in R&D Spend While Advancing Multiple Clinical Programs, Launching Multi-Agentic AI Platform withZeta.ai Commercially, and Strengthening Balance Sheet with Financing of up to $9.25 Million Q1 net loss reduced 27% year-over-year while progressing multiple...
www.pharmiweb.com